Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| Sanofi SAN.PA | Pharmaceuticals: Major | $114B | +17% | +13% | +15% | 27% | 9.7× |
| EssilorLuxottica EL.PA | Medical Specialties | $91.9B | +20% | +5% | +8% | 12% | 24.8× |
| Sartorius Stedim Biotech DIM.PA | Medical Specialties | $24.2B | +5% | +32% | +4% | 19% | 45.7× |
| Ipsen IPN.PA | Pharmaceuticals: Major | $14.8B | +7% | +1% | +14% | 30% | 10.8× |
| bioMerieux BIM.PA | Medical Specialties | $11.8B | +4% | +26% | -3% | 15% | 20.2× |
| Abivax ABVX.PA | Pharmaceuticals: Other | $7.36B | -8% | -30% | n/a | n/a | n/a |
| Virbac VIRP.PA | Biotechnology | $3.20B | +1% | -4% | +4% | 15% | 16.6× |
| Emeis EMEIS.PA | Medical/Nursing Services | $1.78B | +1% | -33% | +4% | 3% | n/a |
| Nanobiotix NANO.PA | Pharmaceuticals: Major | $1.35B | +14% | -32% | -77% | -392% | n/a |
| Clariane CLARI.PA | Medical/Nursing Services | $1.32B | +3% | -20% | +1% | 6% | 8.2× |
| Vetoquinol VETO.PA | Pharmaceuticals: Major | $1.10B | +8% | +19% | -1% | 15% | 15.5× |
| MedinCell MEDCL.PA | Pharmaceuticals: Major | $1.09B | +2% | +4% | -23% | -131% | n/a |
| Ramsay Generale de Sante GDS.PA | Hospital/Nursing Management | $969M | -15% | -25% | +3% | 4% | n/a |
| Inventiva IVA.PA | Biotechnology | $763M | 0% | -36% | -100% | -307,063% | n/a |
| DBV Technologies DBV.PA | Pharmaceuticals: Major | $604M | +2% | -46% | n/a | n/a | n/a |
| Genfit GNFT.PA | Biotechnology | $571M | +16% | +22% | +28% | -130% | 431.5× |
| Valneva VLA.PA | Biotechnology | $508M | -3% | -6% | -27% | -87% | n/a |
| Boiron BOI.PA | Pharmaceuticals: Other | $367M | +6% | -31% | -2% | 5% | 9.3× |